Abstract: The present invention relates to C-Glycosylisoflavones having alkylaminoalkoxyl substituent and pharmaceutically acceptable salts thereof, a process for the preparation thereof, pharmaceutical compositions comprising an effective amount of a compound of the formula (I), and to the use of these compounds or compositions for the treatment or prevention of cardio- and cerebrovascular diseases, in particular for the treatment of various cardiocerebral hypoxic-ischemic diseases, for the treatment or prevention of diabetes mellitus and complications thereof, and for the treatment or prevention of chemical poisoning, in particular alcoholism.
Type:
Grant
Filed:
July 2, 2004
Date of Patent:
June 1, 2010
Assignees:
Hainan Yangpu New & Special Medicine Co., Ltd., Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA
Inventors:
Lin Wang, Qiujun Lu, Shengqi Wang, Tao Peng, Xiaowei Zhu, Shouguo Zhang, Jianping Ren, Lu Li, Ling Han, Yiguang Jin, Fengsheng Che